Document is current
Any future updates will be listed below
-
Authors
Duque-Afonso, Jesús https://orcid.org/0000-0002-8287-5673
Rassner, Paraschiva
Walther, Kristin
Ihorst, Gabriele https://orcid.org/0000-0002-8091-1589
Wehr, Claudia https://orcid.org/0000-0002-5037-6175
Marks, Reinhard
Wäsch, Ralph https://orcid.org/0000-0002-0813-3444
Bertz, Hartmut https://orcid.org/0000-0002-3805-8123
Köhler, Thomas
Frye, Björn Christian
Stolz, Daiana
Zeiser, Robert https://orcid.org/0000-0001-6565-3393
Finke, Jürgen https://orcid.org/0000-0002-1799-5927
Maas-Bauer, Kristina https://orcid.org/0000-0003-1788-2807
- License Information
-
More Information
Article History
Received: 22 June 2024
Revised: 9 September 2024
Accepted: 16 September 2024
First Online: 27 September 2024
Competing interests
: The authors declare no conflicting financial interest with the submission of this article. JF received research support and speakers honoraria from Medac, Neovii and Riemser. JD-A received speaker’s honoraria from Roche, Amgen, AstraZeneca, Riemser, Sobi, Lilly, Beigene and Ipsen and travel support from Gilead, Sobi, Beigene, Alexion and Abbvie. RZ received speaker’s honoraria from Incyte, Novartis, Roche and Mallinckroth. D Stolz reports personal fees from CSL Behring, Berlin-Chemie Menarini, Novartis, GlaxoSmithKline, AstraZeneca, Vifor, Merck, Chiesi, Grifols, MSD, Merck, Sanofi, Roche, Boehringer-Ingelheim and Pfizer, and participation on advisory boards for CSL Behring, Berlin-Chemie, Menarini, Novartis, Boehringer-Ingelheim, GlaxoSmithKline, AstraZeneca, Vifor, Merck, Chiesi, Roche, Grifols, MSD, Merck and Sanofi. This project was supported by a grant of the German Federal Ministry of Education and Research (BMBF 01 EO 0803). JD-A received support from Else Kröner-Fresenius-Stiftung (Nr. 2018-A56). JD-A received research support from German Research Foundation (Deutsche Forschungsgemeinschaft, ref. DU 1287/3-1 and 1287/5-1), from the Forschungskommission of the University of Freiburg Medical School (DUQ1106/16) and Berta Ottenstein-Programm for Advanced Clinician Scientists, Faculty of Medicine, University of Freiburg. KM-B received support from Else-Kröner-Fresenius-Stiftung (2021_EKEA.131), the Berta-Ottenstein Program (Faculty of Medicine, Freiburg University), and the IMMediate Advanced Clinician Scientist-Program, Department of Medicine II, Medical Center – University of Freiburg and Faculty of Medicine, University of Freiburg, funded by the Bundesministerium für Bildung und Forschung (BMBF, Federal Ministry of Education and Research) - 01EO2103.
